Sfoglia per Autore
Comparative risk/benefit profile of biosimilar and originator erythropoiesis-stimulating agents (ESAs): data from an Italian observational study in nephrology
2018 Motola, Domenico*; Vaccheri, Alberto; Roncadori, Andrea; Donati, Monia; Bonaldo, Giulia; Covezzoli, Anna; Polidori, Piera; Bianchi, Stefano
Non-commercial trials on medicines submitted to the Ethics Committee of the University Hospital of Bologna (Italy) along 8 years of activity: time to update rules and recommendations
2019 Montanaro N.; Bonaldo G.; Proni S.; Chiabrando G.; Motola D.
Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017
2019 Bonaldo G.; Vaccheri A.; D'Annibali O.; Motola D.
Antibacterial prescription in Italian preschool children: analysis of 7 years of data from the Emilia-Romagna region reimbursement database
2019 D'Annibali O.; Bonaldo G.; Donati M.; Smabrekke L.; Motola D.; Vaccheri A.
Cardiovascular safety of macrolide and fluoroquinolone antibiotics: An analysis of the WHO database of adverse drug reactions
2019 Bonaldo G.; Andriani L.A.; D'Annibali O.; Motola D.; Vaccheri A.
Evaluation of the safety profile of rotavirus vaccines: a pharmacovigilance analysis on American and European data
2020 Bonaldo G.; Noseda R.; Ceschi A.; Vaccheri A.; Motola D.
Drug-induced disseminated intravascular coagulation: a pharmacovigilance study on World Health Organization’s database
2020 Bonaldo G.; Vaccheri A.; Melis M.; Motola D.
Direct-acting oral anticoagulants and alopecia: The valuable support of postmarketing data
2020 Bonaldo G.; Vaccheri A.; Motola D.
The prescription of antimicrobials by general practitioners: the differences between north and south Italian provinces
2020 Bonaldo G.; Bianchi S.; Ancona D.; Procacci C.; Natalini N.; Motola D.; Vaccheri A.
Human papilloma virus vaccination in males: A pharmacovigilance study on the Vaccine Adverse Event Reporting System
2021 Bonaldo G.; Montanaro N.; Vaccheri A.; Motola D.
Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice
2021 Bonaldo G.; Montanaro N.; AlbertoVaccheri; Motola D.
Removal of the EMA orphan designation upon request of the sponsor: cui prodest?
2021 Montanaro N.; Bonaldo G.; Motola D.
Adverse event reporting with immune checkpoint inhibitors in older patients: Age subgroup disproportionality analysis in vigibase
2021 Noseda R.; Bonaldo G.; Motola D.; Stathis A.; Ceschi A.
Level of therapeutic innovation from the registration studies of the new drugs for the prophylaxis of migraine
2022 Motola D.; Santi Laurini G.; Bonaldo G.; Montanaro N.
Safety profile of hydroxychloroquine used off-label for the treatment of patients with COVID-19: A descriptive study based on EudraVigilance data
2022 Motola D.; Bonaldo G.; Montanaro N.
Real-life safety profile of mRNA vaccines for COVID-19: An analysis of VAERS database
2023 Santi Laurini G.; Montanaro N.; Broccoli M.; Bonaldo G.; Motola D.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile